FibroBiologics, Inc. Common Stock (FBLG) financials · $24.0M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
FibroBiologics, Inc. Common Stock (FBLG) $24.0M cap.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Operating Income | −$16.65M | −$13.74M | |
| Net Income | −$18.65M | −$11.16M | |
| EPS (Diluted) | −$0.42 | −$0.34 | |
| Unlock 4 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $9.62M | $16.45M | |
| Current Assets | $6.35M | $14.23M | |
| Cash & Equivalents | $4.89M | $13.98M | |
| PP&E | $842.00K | $824.00K | |
| Total Liabilities | $3.46M | $13.71M | |
| Current Liabilities | $1.76M | $12.73M | |
| Shareholders' Equity | $6.16M | $2.73M | |
| Retained Earnings | −$54.16M | −$35.52M |
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$16.39M | −$11.90M | |
| CapEx | $262.00K | $184.00K | |
| Investing Cash Flow | −$262.00K | −$184.00K | |
| Financing Cash Flow | $7.57M | $16.91M | |
| Net Change in Cash | −$9.09M | $4.82M | |
| Free Cash Flow | −$16.66M | −$12.09M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is FBLG P/E and revenue?
FibroBiologics, Inc. Common Stock (FBLG) $24.0M cap.
What is FBLG revenue?
FBLG income-statement cache has no revenue figure yet.
Is FBLG profitable?
FibroBiologics, Inc. Common Stock last cached net income is -$18.6M (FY2025).
What are FBLG total assets?
FibroBiologics, Inc. Common Stock last cached total assets are $9.62M (FY2025).
What is FBLG free cash flow?
FibroBiologics, Inc. Common Stock last cached free cash flow is -$16.7M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.